Allysine and α-Aminoadipic Acid as Markers of the Glyco-Oxidative Damage to Human Serum Albumin under Pathological Glucose Concentrations.
Carolina LunaAlexis ArjonaCarmen DueñasMarta Suely MadrugaPublished in: Antioxidants (Basel, Switzerland) (2021)
Understanding the molecular basis of the disease is of the utmost scientific interest as it contributes to the development of targeted strategies of prevention, diagnosis, and therapy. Protein carbonylation is a typical feature of glyco-oxidative stress and takes place in health disorders such as diabetes. Allysine as well as its oxidation product, the α-amino adipic acid (α-AA) have been found to be markers of diabetes risk whereas little is known about the chemistry involved in its formation under hyperglycemic conditions. To provide insight into this issue, human serum albumin was incubated in the presence of FeCl3 (25 μM) and increasing glucose concentrations for 32 h at 37 °C. These concentrations were selected to simulate (i) physiological fasting plasma concentration (4 mM), (ii) pathological pre-diabetes fasting plasma concentration (8 mM), and pathological diabetes fasting plasma concentration (12 mM) of glucose. While both allysine and α-AA were found to increase with increasing glucose concentrations, the carboxylic acid was only detected at pathological glucose concentrations and appeared to be a more reliable indicator of glyco-oxidative stress. The underlying chemical mechanisms of lysine glycation as well as of the depletion of tryptophan and formation of fluorescent and colored advanced glycation products are discussed.
Keyphrases
- blood glucose
- glycemic control
- type diabetes
- human serum albumin
- oxidative stress
- cardiovascular disease
- insulin resistance
- machine learning
- dna damage
- public health
- ischemia reperfusion injury
- weight loss
- deep learning
- risk assessment
- small molecule
- amino acid
- quantum dots
- adipose tissue
- skeletal muscle
- bone marrow
- diabetic rats
- stem cells
- nitric oxide
- human health